Miles & Stockbridge P.C. continues the strategic expansion of its Intellectual Property Practice with the addition of seven lawyers and a patent agent. On August 26th, the firm will welcome Susan McBee, Chester Moore, and David Woodward as principals; Richard Henderson as of counsel; Bryan Jones and David Vanik as counsel; and Shazi Jiang as an associate. All were previously with the Washington, D.C. office of Baker, Donelson, Bearman, Caldwell & Berkowitz, PC. William Brett Stauffer, a registered patent agent, will also join the firm.
“This group is a tremendous addition to our growing Intellectual Property Practice, particularly in matters related to the biotechnology, pharmaceutical, and chemistry fields,” said John B. Frisch, chairman and chief executive officer of Miles & Stockbridge. “Not only are the lawyers experienced in the full spectrum of patent representation, they also deepen our Post-Grant Team and our work involving the new proceedings introduced under the America Invents Act.”
Miles & Stockbridge’s Intellectual Property Practice has grown considerably in 2013. In April, Michael R. Fleming, the former Chief Administrative Patent Judge of the U.S. Patent and Trademark Office (USPTO), joined the firm. Six weeks later, the firm announced that four more registered patent attorneys had recently joined the practice: Barry S. Goldsmith, Adam M. Treiber, Troy L. Gwartney, and Keith Mullervy. In July, the firm welcomed Michael A. Messina, another experienced patent lawyer.
“Joining Miles & Stockbridge represents the next logical step in my practice and that of my colleagues,” said McBee, who previously served as chair of Baker Donelson’s Life Sciences Intellectual Property Team in Washington, D.C. “This is a growing group of IP professionals with deep experience in the issues our clients face every day. We look forward to being a part of this impressive team.”
Below is additional information on the seven registered patent attorneys and one registered patent agent joining Miles & Stockbridge.
Susan E. McBee has more than 25 years of experience in patent and trademark management and 15 years of experience representing Fortune 500 companies engaged in the chemical, biotechnology, pharmaceutical, neutraceutical, and engineering fields, including agricultural chemistry, polymer chemistry, fermentation and extraction of proteins, food additives and processes, small molecule chemistry, genetic engineering, biotechnology, medical devices, metallurgy, packaging, and electronics. She also represents clients in post-grant proceedings, including ex parte reexaminations and inter partes reviews, before the Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark Office (USPTO). Earlier in her career, Ms. McBee owned a patent search company and worked as a patent examiner with the USPTO.
Chester G. (C.G.) Moore, Ph.D. focuses his practice in the fields of biotechnology and chemistry, with a particular emphasis on molecular and cellular biology, small molecule chemistry, medical devices, agricultural chemistry, and food additives. Dr. Moore has broad experience in the preparation and prosecution of patent applications, post-grant proceedings, and patent strategy and management. Earlier in his career, Dr. Moore worked at institutions including Johns Hopkins University School of Medicine, Massachusetts General Hospital, Tulane University Office of Technology Transfer, and the Transplant Resource Center of Maryland.
David W. Woodward has more than 25 years of experience in patent prosecution, reexamination, reissue and appeal matters for clients in the pharmaceutical, chemical and biotech industries. Like McBee, he represents clients in post-grant proceedings before the PTAB of the USPTO and was a patent examiner with the USPTO earlier in his career.
Richard E. L. Henderson, Ph.D. brings significant experience in patent and trademark prosecution, licensing agreements, and opinion work to the firm. Dr. Henderson served as senior patent counsel and head of the patent group at Bayer CropScience LP for nine years and as patent counsel for Bayer Corporation for 14 years. While at the Bayer Corporation, he was responsible for intellectual property matters for the company’s Industrial Chemicals Division. Dr. Henderson was previously a patent attorney with Merck and a patent agent with G. D. Searle.
Bryan W. Jones focuses on the procurement and enforcement of patents and trademarks in the biotechnological, metallurgical, pharmaceutical, nutraceutical, and crop science industries. Mr. Jones has assisted clients with the prosecution of patent applications regarding cancer immunotherapeutics, molecular diagnostic assays, herbicidal and insecticidal compounds and compositions, polymer compositions and products, and aluminum alloys and products. He also represents clients in post-grant proceedings.
David L. Vanik, Ph.D. focuses his practice on patent prosecution and counseling, opinion work, and patent strategy and management in the chemical and biotechnology industries. Dr. Vanik prosecutes patent applications related to biotechnology, plants, chemical compounds, small-molecules, pharmaceutical compositions, and antibodies and proteins. He offers significant experience in working with international patent associates to help secure foreign patent rights for U.S. clients. Like McBee and Woodward, Dr. Vanik represents clients in post-grant proceedings and served as a patent examiner with the USPTO.
Shazi Jiang, M.D. offers significant experience in life science. With degrees in both medicine and law, Dr. Jiang focuses her legal practice on the biotechnological, metallurgical, pharmaceutical, nutraceutical, and crop science industries. She is fluent in Mandarin Chinese.
William Brett Stauffer is a registered patent agent and 2013 law graduate, who will work with the lawyers on intellectual property matters in the chemical, biochemical, pharmaceutical, nutraceutical, biotechnology, and engineering fields.
